Epstein-Barr virus (EBV) is a human lymphotropic herpesvirus which is the etiologic agent of infectious mononucleosis, a self-limiting lymphoproliferative disorder. In addition, EBV is closely associated with two human cancers, African Burkitt's lymphoma (BL) and nasopharyngeal carcinoma (NPC), and also appears to be associated with a significant percentage of Hodgkin's lymphoma (HD) as well as the non-Hodgkin's lymphoms that arise in immunosuppressed patients. The role of EBV in lymphomagenesis has remained enigmatic. While viral gene expression in the EBV-associated non-Hodgkin's large cell lymphomas that arise in immunosupppressed individuals mirrors that observed in B lymphocytes immortalized by EBV in tissue culture, the recently characterized restricted pattern of viral gene expression in African Burkitt's lymphoma (BL) raises important questions about the role of EBV in the etiology of these tumors. Addressing these questions will require a thoroug understanding of how restricted EBV latency is regulated. It is critical to determine whether restricted latency is a normal viral program, or whether it is brought about by selection during lymphomagenesis. One of the important long range goals of this research is to determine whether this form of restricted viral latency occurs in normal seropositive individuals. We propose to focus on regulation of viral gene expression in group 1 Burkitt's lymphoma cell lines, and to assess whether infection of some population of normal peripheral B lymphocytes results in restricted latency, as follows: 1. characterize the roles of Fp and the newly identified Qp in driving transcription of the EBNA 1 gene in group 1 BL cell lines; 2. characterize the viral genomes present in group 1 BL cell lines and clone the critical control regions of the EBNA 1 gene promoter from a representative group 1 BL cell line; 3. assay EBV infection time courses of peripheral blood B lymphocytes for presence of the restricted EBNA 1 transcription pattern; 4. investigate alternative splicing from the U exon to the EBNA 3a, EBNA 3c and EBNA 1 coding exons; and 5. generate a recombinant EBV harboring mutations in the low ffinity EBNA 1 binding sites in the viral BamHI Q fragment, and assess the impact of these mutations on EBNA 1 gene transcription in primary B cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA058524-01A2
Application #
2099201
Study Section
Experimental Virology Study Section (EVR)
Project Start
1995-08-01
Project End
1999-05-31
Budget Start
1995-08-01
Budget End
1996-05-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Paden, Clinton R; Forrest, J Craig; Moorman, Nathaniel J et al. (2010) Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J Virol 84:7214-24
Gray, Kathleen S; Forrest, J Craig; Speck, Samuel H (2010) The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency. J Virol 84:4946-59
Siegel, Andrea M; Rangaswamy, Udaya Shankari; Napier, Ruth J et al. (2010) Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J Virol 84:674-85
Collins, Christopher M; Boss, Jeremy M; Speck, Samuel H (2009) Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J Virol 83:6484-93
Krug, Laurie T; Collins, Christopher M; Gargano, Lisa M et al. (2009) NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency. J Virol 83:4732-48
Herskowitz, Jeremy H; Siegel, Andrea M; Jacoby, Meagan A et al. (2008) Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J Virol 82:3295-310
Forrest, J Craig; Speck, Samuel H (2008) Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade. J Virol 82:7688-99
Siegel, Andrea M; Herskowitz, Jeremy H; Speck, Samuel H (2008) The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog 4:e1000039
DeZalia, Mark; Speck, Samuel H (2008) Identification of closely spaced but distinct transcription initiation sites for the murine gammaherpesvirus 68 latency-associated M2 gene. J Virol 82:7411-21
Gargano, Lisa M; Moser, Janice M; Speck, Samuel H (2008) Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol 82:3853-63

Showing the most recent 10 out of 38 publications